SHANNON KING: Open Payments
NPI 1750752861 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 36 payments from 18 companies in 2025. Trend: 2023 $1,197 · 2024 $1,200 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| Indivior Inc. | 2 | $64 |
| Dexcom, Inc. | 3 | $63 |
| Amgen Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Abbott Laboratories | 2 | $38 |
| ABBVIE INC. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
Products named: Kerendia, SUBLOCADE, Dexcom G6 Transmitter, REXULTI, CAPLYTA, FREESTYLE LIBRE 3, VRAYLAR, EVENITY.
Industry payments across AZ — which companies pay providers there.
